The European League Against Rheumatism (EULAR)-18th Annual European Congress of Rheumatology

被引：0
|
作者：
Walker, K. [1 ]
机构：
[1] Clarivate Analyt, London, England
来源：
DRUGS OF THE FUTURE | 2017年 / 42卷 / 08期
关键词：
SM-04690; Lutikizumab; GLPG-1972; Seletalisib; BCD-055; Filgotinib; Tadekinig alfa; AMG-557; MEDI-9600; Iberdomide; E-6011; BMS-986165;
D O I：
10.1358/dof.2017.042.08.2676121
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The 18th European League Against Rheumatism (EULAR) meeting saw a record number of over 4,850 abstracts, and with 14,000 delegates expected, was set to bring together patients, doctors, scientists, health professionals and pharma industry professionals to share, collaborate and accelerate progress in the field of rheumatology. This report provides highlights from both oral and poster sessions from the meeting.
引用
收藏
页码：523 / 528
页数：6
相关论文
共 50 条
12345